Shareholders meeting

August 14, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai – 400 051. Dalal Street, Mumbai – 400 001. Scrip Code: STAR Scrip Code: 532531 Dear Madam/ Sir, Sub: Proceedings of the 35th Annual General Meeting (AGM) of the Company We wish to inform you that the 35th AGM of the Company was held on Friday, August 14, 2026 at 12:15 hrs IST through video conference and ended at 13:34 hrs IST. Pursuant to Regulation 30, Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed summary of proceedings of the AGM. This is for your information and records. Thanks & Regards, For Strides Pharma Science Limited Manjula Ramamurthy Company Secretary ICSI Membership No.: A30515 Encl. as above Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000 Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924/3199 corpcomm@strides.com; www.strides.com SUMMARY OF PROCEEDINGS OF 35TH ANNUAL GENERAL MEETING OF THE COMPANY HELD ON FRIDAY, AUGUST 14, 2026, FROM 12:15 HRS IST TO 13:34 HRS IST THROUGH VIDEO CONFERENCE. Ms. Manjula Ramamurthy, Company Secretary of the Company, welcomed the Shareholders to the 35th Annual General Meeting (‘AGM’) of the Company, which was held through video conference and in compliance with the applicable provisions of the Companies Act, 2013 read with the Rules framed thereunder, Secretarial Standards, SEBI Listing Regulations, 2015 and various applicable Circulars issued by MCA and SEBI in this regard. Thereafter, Board Members and other Invitees present at the meeting were introduced to the Shareholders and the following was noted: Directors and officials present The following Directors and senior officials attended the meeting: Name Designation Mr. Arun Kumar Founder and Non-Executive Chairperson Dr. Kausalya Santhanam Independent Director and Chairperson of CSR Committee and Stakeholders’ Relationship Committee Ms. Mukta Arora Independent Director Mr. Homi Khusrokhan Independent Director and Chairperson of Audit Committee and Risk Management Committee Mr. Ameet Hariani Independent Director and Chairperson of Nomination and Remuneration Committee Mr. Subir Chakraborty Independent Director Mr. Aditya Arun Kumar Non- Executive Director Mr. Badree Komandur Managing Director and Group CEO Mr. Ramaraju PVS Executive Director Mr. Vikesh Kumar Group CFO Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000 Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924/3199 corpcomm@strides.com; www.strides.com Other invitees present The representatives of B S R & Co. LLP, Chartered Accountants, Statutory Auditors; Grant Thornton Bharat LLP, Internal Auditors; Sreedharan & Associates, the Secretarial Auditors; and Mr. Gigi Joseph K J, Partner of M/s. Joseph and Chacko LLP, Company Secretaries, Bengaluru, (who was appointed as Scrutinizer for the e-voting process) were present at the meeting. Quorum and commencement of meeting KFin Technologies Limited, Registrar and Transfer Agent of the Company, confirmed the presence of the requisite quorum for the meeting. Thereafter, Mr. Arun Kumar, Chairperson, chaired the meeting, called the meeting to order and greeted the shareholders. The Chairperson then requested Mr. Badree Komandur, Managing Director and Group CEO, to brief the shareholders on the Company’s performance for the financial year ended March 31, 2026 and other relevant matters. Shareholder interaction Following the presentation by Mr. Badree Komandur, the speaker shareholders who had registered with the Company were provided an opportunity to express their views and raise queries on the Company’s performance and the agenda items set out in the AGM Notice. The queries raised by the shareholders were suitably responded to by Mr. Badree Komandur. Documents taken as read and inspection facility With the consent of the shareholders, the AGM Notice convening the meeting, the Board’s Report and the Auditor’s Report for the financial year ended March 31, 2026 were taken as read, as these documents had already been circulated to the shareholders. The shareholders were informed that the Auditor’s Reports on the Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026 did not contain any qualifications, observations or adverse comments. The shareholders were further informed that the requisite statutory registers and other documents referred to in the AGM Notice were available for electronic inspection. The certificate issued by the Secretarial Auditor, certifying that the existing ESOP Scheme of the Company had been implemented in accordance with the applicable SEBI Regulations and in line with the approval of the shareholders, was also available for electronic inspection. Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000 Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924/3199 corpcomm@strides.com; www.strides.com Business transacted at the AGM The following items of business, as set out in the AGM Notice, were transacted at the meeting: # Resolutions Description Type of Resolution Ordinary Business 1 To receive, consider and adopt the Audited Financial Statements of the Company Ordinary (including Consolidated Financial Statements) for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and Auditors thereon. 2 Declaration of Final Dividend for the Financial Year ended March 31, 2026. Ordinary 3 Re-appointment of Mr. Arun Kumar, retiring Director. Ordinary Special Business 4 Payment of Commission to Non-Executive Directors of the Company in the event of Special inadequacy of profit. 5 Appointment of Mr. Aditya Arun Kumar as Non‑Executive Director. Ordinary 6 Appointment of Mr. Venkata Seetharama Raju Pakalapati as Executive Director. Special E-voting at the AGM and declaration of results Shareholders were informed that the insta-voting facility would remain available for those shareholders who had not cast their votes during the remote e-voting period. Accordingly, such shareholders were provided the facility to cast their votes electronically at the AGM for the next 30 minutes. Shareholders were further informed that the voting results, along with the Scrutinizer’s Report, would be declared within two working days from the conclusion of the AGM, i.e., on or before Tuesday, August 18, 2026. Conclusion There being no other business to transact, the meeting concluded with a vote of thanks by the Chairperson. For Strides Pharma Science Limited, Manjula Ramamurthy Company Secretary ICSI Membership No.: A30515 Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000 Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924/3199 corpcomm@strides.com; www.strides.com